Foreign Drug Firm Registration Reg Will Help FDA Track Counterfeits
This article was originally published in The Tan Sheet
Executive Summary
FDA's ability to track counterfeit and impure drugs is expected to be enhanced by implementation of a final rule requiring foreign drug companies to register and list their products with the agency